Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 30;20(9):e1012575.
doi: 10.1371/journal.ppat.1012575. eCollection 2024 Sep.

Put a little doxy-PEP in your step: Using doxycycline to prevent chlamydia, syphilis, and gonorrhea infections

Eric A Meyerowitz  1   2 , Rina Liang  1   2 , Derek Bishop  2 , Caroline E Mullis  1   2
Affiliations

Put a little doxy-PEP in your step: Using doxycycline to prevent chlamydia, syphilis, and gonorrhea infections

Eric A Meyerowitz et al. PLoS Pathog. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors report no competing interests for this work.

References

    1. Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV prevention: Where have we been and where are we going? J Acquir Immune Defic Syndr. 2013. Jul 1;63(Supplement 2):S122–S129. - PMC - PubMed
    1. Bachmann LH, Barbee LA, Chan P, Reno H, Workowski KA, Hoover K, et al.. CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024. MMWR Recomm Rep. 2024. Jun 6;73(2):1–8. doi: 10.15585/mmwr.rr7302a1 - DOI - PMC - PubMed
    1. Luetkemeyer AF, Donnell D, Dombrowski JC, Cohen S, Grabow C, Brown CE, et al.. Postexposure doxycycline to prevent bacterial sexually transmitted infections. N Engl J Med. 2023. Apr 6;388(14):1296–1306. doi: 10.1056/NEJMoa2211934 - DOI - PMC - PubMed
    1. Molina JM, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, et al.. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018. Mar;18(3):308–317. doi: 10.1016/S1473-3099(17)30725-9 - DOI - PubMed
    1. Molina JM, Bercot B, Assoumou L, Rubenstein E, Algarte-Genin M, Pialoux G, et al.. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): A multicentre, open-label, randomised trial with a 2 × 2 factorial design. Lancet Infect Dis. 2024. May;S1473309924002366. - PubMed

MeSH terms